Remaining parasitaemic at 24 hours · Adults and children with uncomplicated P. vivax malaria
Summary of findings: ACT leads to lower remaining parasitaemic at 24 hours compared with CQ (high certainty).
1 finding from 1 review
Remaining febrile after 24 hours · Adults and children with uncomplicated P. vivax malaria
Summary of findings: ACT probably leads to lower remaining febrile after 24 hours compared with CQ (moderate certainty).
1 finding from 1 review
Effective treatment of the blood stage parasite As assessed by: Recurrent parasitaemia before day 28 · Adults and children with uncomplicated P. vivax malaria
Summary of findings: ACT showed no clear difference in effective treatment of the blood stage parasite As assessed by:… compared with CQ (high certainty).
1 finding from 1 review
Post‐treatment prophylaxis As assessed by: Recurrent parasitaemia between day 28 and day 42/56/63 · Adults and children with uncomplicated P. vivax malaria
Summary of findings: ACT may leads to lower post‐treatment prophylaxis As assessed by: Recurrent parasitaemia… compared with CQ (low certainty).
1 finding from 1 review
Serious adverse events · Adults and children with uncomplicated P. vivax malaria
Summary of findings: ACT showed no clear difference in serious adverse events compared with CQ (high certainty).
1 finding from 1 review
Effective treatment of the blood stage parasite As assessed by: Recurrent parasitaemia before day 28 · Adults and children with uncomplicated P. vivax malaria
Summary of findings: DHA‐P probably leads to lower effective treatment of the blood stage parasite As assessed by:… compared with alternative ACTs (moderate certainty).
1 finding from 1 review
Post treatment prophylaxis As assessed by: Recurrent parasitaemia between day 28 and 42 · Adults and children with uncomplicated P. vivax malaria
Summary of findings: DHA‐P may leads to lower post‐treatment prophylaxis As assessed by: Recurrent parasitaemia… compared with alternative ACTs (low certainty).
1 finding from 1 review
Intervention not reported
ETEC diarrhoea · People travelling from non‐endemic settings
The intervention showed no clear difference in ETEC diarrhoea (low certainty).
1 finding from 1 review
Intervention not reported
Severe ETEC diarrhoea · People travelling from non‐endemic settings
1 finding from 1 review
Intervention not reported
All‐cause diarrhoea · People travelling from non‐endemic settings
The intervention showed no clear difference in all‐cause diarrhoea (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · People travelling from non‐endemic settings
1 finding from 1 review
Duration of diarrhoea · patients symptomatic for NTS infection
1 finding from 1 review
Fever clearance time · patients symptomatic for NTS infection
1 finding from 1 review
Duration of illness · patients symptomatic for NTS infection
1 finding from 1 review
Clinical treatment failure (Persistent or worsening symptoms at the end of treatment) · patients symptomatic for NTS infection
It is very uncertain whether antibiotics changes clinical treatment failure (Persistent or worsening symptoms at the… compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Diarrhoea · patients symptomatic for NTS infection
It is very uncertain whether antibiotics changes presence of diarrhoea at 2‐4 days compared with placebo or no treatment (very low certainty).
2 findings from 1 review
FCT · patients with fever in malaria
1 finding from 1 review
PCT · patients with fever in malaria
1 finding from 1 review
Adverse events · patients with fever in malaria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinical malaria · Children aged less than 5 years
The intervention leads to lower clinical malaria (high certainty).
1 finding from 1 review